OnCo
targetsTarget

STMN1

aka stathmin 1, Stathmin, OP18, PR22, PP19, PP17, Lag, FLJ32206, LAP18, C1orf215

STMN1 (Stathmin) is a gene. The public catalogues list it as a drug target and a biomarker, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Endometrial cancer.